Search research articles
Contact Us
Filters
Showing results (1-10 of 113) with videos related to
Page
of 12
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
April 25, 2012
High-throughput assays to measure intracellular Ca²⁺ mobilization in cells that express recombinant S1P receptor subtypes
William J Valentine, Gabor Tigyi
Advances in Experimental Medicine and Biology
|
September 7, 2020
Druggable Lysophospholipid Signaling Pathways
Keisuke Yanagida, William J Valentine
Biochimie
|
August 23, 2023
Lysophospholipid acyltransferases orchestrate the compositional diversity of phospholipids
William J Valentine, Takao Shimizu, Hideo Shindou
Journal of Managed Care Pharmacy : JMCP
|
March 30, 2013
Evaluating the short-term cost-effectiveness of liraglutide versus sitagliptin in patients with type 2 diabetes failing metformin monotherapy in the United States
Jakob Langer, Barnaby Hunt, William J Valentine
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 10, 2026
Cost-Effectiveness of Highly Effective Glucose-Lowering Agents: Do Current Practices Optimize Clinical and Economic Outcomes?
Meredith Hoog, Alice Minghetti, William J Valentine
Journal of Medical Economics
|
June 24, 2009
Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries
Manuela Helena Gschwend, Mark Aagren, William J Valentine
Advances in Therapy
|
May 21, 2024
Utilities for Complications Associated with Type 2 Diabetes: A Review of the Literature
William J Valentine, Kirsi Norrbacka, Kristina S Boye
Biochimica Et Biophysica Acta
|
October 13, 2007
Lysophospholipid signaling: beyond the EDGs
William J Valentine, Yuko Fujiwara, Ryoko Tsukahara, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 29, 2017
IDegLira Versus Insulin Glargine U100: A Long-term Cost-effectiveness Analysis in the US Setting
Barnaby Hunt, Michelle Mocarski, William J Valentine, et al.
Journal of Medical Economics
|
March 15, 2012
A long-term analysis evaluating the cost-effectiveness of biphasic insulin lispro mix 75/25 and mix 50/50 versus long-acting basal insulin analogs in the United States
Richard F Pollock, Bradley H Curtis, William J Valentine
Page
of 12
Search research articles
Search
Showing results (1-10 of 113) with videos related to
Sort By:
Page
of 12
Methods in Molecular Biology (Clifton, N.J.)
|
April 25, 2012
High-throughput assays to measure intracellular Ca²⁺ mobilization in cells that express recombinant S1P receptor subtypes
William J Valentine, Gabor Tigyi
Advances in Experimental Medicine and Biology
|
September 7, 2020
Druggable Lysophospholipid Signaling Pathways
Keisuke Yanagida, William J Valentine
Biochimie
|
August 23, 2023
Lysophospholipid acyltransferases orchestrate the compositional diversity of phospholipids
William J Valentine, Takao Shimizu, Hideo Shindou
Journal of Managed Care Pharmacy : JMCP
|
March 30, 2013
Evaluating the short-term cost-effectiveness of liraglutide versus sitagliptin in patients with type 2 diabetes failing metformin monotherapy in the United States
Jakob Langer, Barnaby Hunt, William J Valentine
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 10, 2026
Cost-Effectiveness of Highly Effective Glucose-Lowering Agents: Do Current Practices Optimize Clinical and Economic Outcomes?
Meredith Hoog, Alice Minghetti, William J Valentine
Journal of Medical Economics
|
June 24, 2009
Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries
Manuela Helena Gschwend, Mark Aagren, William J Valentine
Advances in Therapy
|
May 21, 2024
Utilities for Complications Associated with Type 2 Diabetes: A Review of the Literature
William J Valentine, Kirsi Norrbacka, Kristina S Boye
Biochimica Et Biophysica Acta
|
October 13, 2007
Lysophospholipid signaling: beyond the EDGs
William J Valentine, Yuko Fujiwara, Ryoko Tsukahara, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 29, 2017
IDegLira Versus Insulin Glargine U100: A Long-term Cost-effectiveness Analysis in the US Setting
Barnaby Hunt, Michelle Mocarski, William J Valentine, et al.
Journal of Medical Economics
|
March 15, 2012
A long-term analysis evaluating the cost-effectiveness of biphasic insulin lispro mix 75/25 and mix 50/50 versus long-acting basal insulin analogs in the United States
Richard F Pollock, Bradley H Curtis, William J Valentine
Page
of 12